Contact HealthDay
Tel: 203.855.1400 or E-mail

News By Specialty

Allergy
Anesthesiology
Cardiology
Cosmetic Surgery
Critical Care
Dermatology
Diabetes & Endocrinology
Emergency Medicine
Family Practice
Gastroenterology
Geriatrics
Hematology & Oncology
HIV & AIDS
Infectious Disease
Internal Medicine
Nephrology
Neurology
Nursing
OBGYN & Women's Health
Ophthalmology
Orthopedics
Otolaryngology
Pain Management
Pathology
Pediatrics
Pharmacy
Psychiatry
Pulmonology
Radiology
Rheumatology
Surgery
Urology

Follow us on:

    


e-Healthcare Leadership Awards


FDA Approves Botox for Overactive Bladder
When patients don't respond to standard treatments
This article is older than one year and is no longer available.

Copyright © 2013 HealthDay. All rights reserved.

August 31, 2015

Archive Search

By Keyword:
By Category:
By Topic:

Related Articles

AMA: Ruling Makes It Easier for Insurers to Terminate Doctors

Sleep Deprived Surgeons Appear to Be Self-Regulating Well

FDA Issues Proposal on Lower-Cost, Generic Biotech Drugs

Women in Academic Medicine 'Manage Femininity' to Succeed

Parents More Likely to Use Abx for 'Pink Eye' vs 'Eye Infection'

Psychological Features Impact Myofascial Paraspinous Pain Tx